[Peritoneal dialysis in treatment of end-stage renal disease].

PERITONEAL DIALYSIS IN THE TREATMENT OF END-STAGE RENAL DISEASE. Peritoneal dialysis (PD) is a replacement therapy for patients with stage 5 chronic kidney disease (CKD5). Its use varies from country to country. In France, only 11% of CKD5 patients are treated with PD, with great disparity between regions, the majority being supported with center hemodialysis (HD). Yet this treatment offers many advantages. It is a home-based treatment, allowing greater autonomy, and easy for patients to learn. In the event of incapacity, assistance can be provided by a nurse or a relative. No vascular approach is required. Its effectiveness in terms of patient survival is at least identical to that of HD patients. It is vital that all patients at MRC4 or 5 stage should be managed within the care pathway recommended by Haute Autorité de santé, so that they can benefit, among other things, from informed pre-dialysis information on the different dialysis modalities.